- Home
- DNN vs EVO Comparison
DNN vs EVO Comparison
Compare DNN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- EVO
- Stock Information
- Founded
- DNN 1936
- EVO 1993
- Country
- DNN Canada
- EVO Germany
- Employees
- DNN N/A
- EVO N/A
- Industry
- DNN Other Metals and Minerals
- EVO Biotechnology: Pharmaceutical Preparations
- Sector
- DNN Basic Materials
- EVO Health Care
- Exchange
- DNN Nasdaq
- EVO Nasdaq
- Market Cap
- DNN 1.8B
- EVO 1.5B
- IPO Year
- DNN 1997
- EVO 2021
- Fundamental
- Price
- DNN $1.85
- EVO $4.35
- Analyst Decision
- DNN Strong Buy
- EVO Buy
- Analyst Count
- DNN 2
- EVO 2
- Target Price
- DNN $3.00
- EVO $5.90
- AVG Volume (30 Days)
- DNN 35.6M
- EVO 53.2K
- Earning Date
- DNN 02-27-2025
- EVO 11-06-2024
- Dividend Yield
- DNN N/A
- EVO N/A
- EPS Growth
- DNN N/A
- EVO N/A
- EPS
- DNN N/A
- EVO N/A
- Revenue
- DNN $2,920,167.00
- EVO $866,665,179.00
- Revenue This Year
- DNN $226.79
- EVO $3.89
- Revenue Next Year
- DNN $133.88
- EVO $10.89
- P/E Ratio
- DNN N/A
- EVO N/A
- Revenue Growth
- DNN N/A
- EVO N/A
- 52 Week Low
- DNN $1.40
- EVO $2.85
- 52 Week High
- DNN $2.47
- EVO $7.98
- Technical
- Relative Strength Index (RSI)
- DNN 45.98
- EVO 50.43
- Support Level
- DNN $1.70
- EVO $4.18
- Resistance Level
- DNN $1.93
- EVO $4.54
- Average True Range (ATR)
- DNN 0.11
- EVO 0.11
- MACD
- DNN -0.01
- EVO 0.03
- Stochastic Oscillator
- DNN 34.09
- EVO 64.81
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.